Search - tctmd.com

Displaying 1 - 20 of 1665

Sort: Relevancy | Date

Presentation AHA 2024

Efficacy and safety of EdoxabaN in anticoagulant therapy after surgical Bioprosthetic vALVe replacement

Presenter: Chisato Izumi

November 17, 2024

Presentation AHA 2024

Randomized Comparison of Left Atrial Appendage Closure with Oral Anticoagulation after Catheter Ablation for Atrial Fibrillation

Presenter: Oussama M. Wazni

November 16, 2024

Presentation TCT 2024

TCT 796: Association Between Social Determinants of Health and Aortic Valve Replacement in a Large Community-based Health Care System

Presenter: Daniel Spoon

October 30, 2024

Presentation TCT 2024

TCT 654: Treatment Patterns for Severe Aortic Stenosis in a Large Community-based Health Care System

Presenter: Daniel Spoon

October 30, 2024

Presentation TCT 2024

Patient Considerations

Presenter: Firas Zahr

October 30, 2024

Presentation TCT 2024

Imaging Considerations

Presenter: Rebecca Hahn

October 30, 2024

Presentation TCT 2024

Who to Treat With TTVI?

Presenter: Suzanne Arnold

October 30, 2024

Presentation TCT 2024

The Rise of AHA Target: Aortic Stenosis – Applying Quality Improvement Upstream of the Procedure (in partnership with the American Heart Association)

Presenter: Brian Lindman

October 30, 2024

Presentation TCT 2024

Summary and Next Steps

Presenter: NULL

October 30, 2024

Presentation TCT 2024

Optimizing TAVI with the SavvyWire® Guidewire

Presenter: Rahul Sharma

October 30, 2024

Presentation TCT 2024

Optimizing TAVI Through Standardized Invasive Hemodynamics

Presenter: Ravi Ramana

October 30, 2024

Presentation TCT 2024

LV Pacing in TAVI: Efficiency, Experience, and Expectations

Presenter: Vijay Iyer

October 30, 2024

Presentation TCT 2024

How to Manage After TTVI?

Presenter: Susheel Kodali

October 30, 2024

Presentation TCT 2024

ACURATE IDE Insights: Optimizing Clinical Implants

Presenter: NULL

October 30, 2024

Presentation TCT 2024

A Closer Look at the ACURATE IDE Study

Presenter: NULL

October 30, 2024

Presentation TCT 2024

Patient-Reported Outcomes are a True Measure of TTVI Value

Presenter: John Spertus

October 30, 2024

Presentation TCT 2024

CV Event Reduction is the Essential Criterion for Implementing New Device Therapies

Presenter: Ori Ben-Yehuda

October 30, 2024

Presentation TCT 2024

TCT 870: Prediction Models for the Treatment of Bioprosthetic Aortic Valve Failure in the United States

Presenter: Philippe Genereux

October 30, 2024

Presentation TCT 2024

TCT 869: Insight From Pre and Post Redo-TAV Computed Tomography Assessment: Implication for Sizing, Positioning and Coronary Risk

Presenter: NULL

October 30, 2024

Presentation TCT 2024

TCT 868: Potential Pre-TAVR CT Based Computational Modeling Derived Geometric Predictors of Post-TAVR Leaflet Thrombosis in Self-Expandable Valves

Presenter: Aniket Venkatesh

October 30, 2024

Advertisement

Efficacy and safety of EdoxabaN in anticoagulant therapy after surgical Bioprosthetic vALVe replacement

Randomized Comparison of Left Atrial Appendage Closure with Oral Anticoagulation after Catheter Ablation for Atrial Fibrillation

TCT 796: Association Between Social Determinants of Health and Aortic Valve Replacement in a Large Community-based Health Care System

TCT 654: Treatment Patterns for Severe Aortic Stenosis in a Large Community-based Health Care System

Patient Considerations

Imaging Considerations

Who to Treat With TTVI?

The Rise of AHA Target: Aortic Stenosis – Applying Quality Improvement Upstream of the Procedure (in partnership with the American Heart Association)

Summary and Next Steps

Optimizing TAVI with the SavvyWire® Guidewire

Optimizing TAVI Through Standardized Invasive Hemodynamics

LV Pacing in TAVI: Efficiency, Experience, and Expectations

How to Manage After TTVI?

ACURATE IDE Insights: Optimizing Clinical Implants

A Closer Look at the ACURATE IDE Study

Patient-Reported Outcomes are a True Measure of TTVI Value

CV Event Reduction is the Essential Criterion for Implementing New Device Therapies

TCT 870: Prediction Models for the Treatment of Bioprosthetic Aortic Valve Failure in the United States

TCT 869: Insight From Pre and Post Redo-TAV Computed Tomography Assessment: Implication for Sizing, Positioning and Coronary Risk

TCT 868: Potential Pre-TAVR CT Based Computational Modeling Derived Geometric Predictors of Post-TAVR Leaflet Thrombosis in Self-Expandable Valves

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content